$139,58
-$0,22(-0,15%)
*Data last updated: 2026-04-08 00:44 (UTC+8)
As of 2026-04-08 00:44, Gilead Sciences Inc (GILD) is priced at $139,58, with a total market cap of $172,30B, a P/E ratio of 17,94, and a dividend yield of 2,29%. Today, the stock price fluctuated between $137,09 and $142,00. The current price is 1,81% above the day's low and 1,70% below the day's high, with a trading volume of 5,43M. Over the past 52 weeks, GILD has traded between $137,09 to $142,00, and the current price is -1,70% away from the 52-week high.
GILD Key Stats
Yesterday's Close$140,13
Market Cap$172,30B
Volume5,43M
P/E Ratio17,94
Dividend Yield (TTM)2,29%
Dividend Amount$0,82
Diluted EPS (TTM)6,85
Net Income (FY)$8,51B
Revenue (FY)$29,44B
Earnings Date2026-04-23
EPS Estimate1,86
Revenue Estimate$6,90B
Shares Outstanding1,22B
Beta (1Y)0.404
Ex-Dividend Date2026-03-13
Dividend Payment Date2026-03-30
About GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
SectorHealthcare
IndustryDrug Manufacturers - General
CEODaniel O'Day
HeadquartersFoster City,CA,US
Official Websitehttps://www.gilead.com
Employees (FY)17,00K
Average Revenue (1Y)$1,73M
Net Income per Employee$500,58K
Gilead Sciences Inc (GILD) FAQ
What's the stock price of Gilead Sciences Inc (GILD) today?
x
Gilead Sciences Inc (GILD) is currently trading at $139,58, with a 24h change of -0,15%. The 52-week trading range is $137,09–$142,00.
What are the 52-week high and low prices for Gilead Sciences Inc (GILD)?
x
What is the price-to-earnings (P/E) ratio of Gilead Sciences Inc (GILD)? What does it indicate?
x
What is the market cap of Gilead Sciences Inc (GILD)?
x
What is the most recent quarterly earnings per share (EPS) for Gilead Sciences Inc (GILD)?
x
Should you buy or sell Gilead Sciences Inc (GILD) now?
x
What factors can affect the stock price of Gilead Sciences Inc (GILD)?
x
How to buy Gilead Sciences Inc (GILD) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
